Use of Sofosbuvir-Based Direct-Acting Antiviral Therapy for Hepatitis C Viral Infection in Patients with Severe Renal Insufficiency

Sofosbuvir-based direct-acting antiviral therapy revolutionized the treatment of hepatitis C virus (HCV) infection; however, sofosbuvir use is not approved for patients with severe renal insufficiency [estimated glomerular filtration (eGFR) rate below 30 mL/min] or end stage renal disease (ESRD) bas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Infect Dis (Lond)
Autors principals: Hundemer, Gregory L., Sise, Meghan E., Wisocky, Jessica, Ufere, Nneka, Friedman, Lawrence S., Corey, Kathleen E., Chung, Raymond T.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4732277/
https://ncbi.nlm.nih.gov/pubmed/26365684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/23744235.2015.1078908
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars